Amphetamine Stimulant Prodrug denied as non-formulary by Humana?

Humana's specific coverage criteria for amphetamine stimulant prodrug are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Denied This as Non-Formulary

Humana's formulary (drug list) organizes covered medications into tiers, and an amphetamine-class stimulant prodrug may be placed on a non-preferred tier or excluded from the formulary entirely — particularly if a generic or preferred-brand alternative exists. A non-formulary denial means Humana will not cover the drug at standard cost-sharing without a formulary exception. This is a policy-level default, not a clinical judgment about your specific case.

## Why Formulary Exceptions Are Winnable

Most Humana plans offer a formulary exception process alongside the formal appeal process. An exception is granted when there is clinical evidence that the covered formulary alternatives are contraindicated, have already failed, or are otherwise clinically inappropriate for a specific patient. ACA §2719 and ERISA §503 guarantee the right to a full internal appeal and independent external review regardless of formulary status. External review is generally available for approximately four months after a final internal denial. An expedited option exists for urgent situations.

## Appeal Process and Timeline

1. Identify the formulary alternatives: Humana's denial or formulary lookup tool will show which stimulant agents are covered at standard cost-sharing. 2. Request a formulary exception through your prescriber — this is a parallel, often faster, pathway to coverage and should be pursued at the same time as the formal appeal. 3. File the internal appeal within Humana's deadline (typically 60 days from denial). Humana must respond within 30 days (pre-service) or 60 days (post-service). 4. If denied, request independent external review.

## Documentation to Gather

• Formulary alternative trial history: For each covered alternative that Humana would prefer, document whether it was tried (with dates and outcomes) or why it is clinically inappropriate for this patient.
• Prescriber medical-necessity letter: Explains why the requested non-formulary drug is medically necessary for this patient specifically — not merely preferred — and why formulary alternatives are insufficient.
• Clinical records: Office notes corroborating the prescriber's letter, including the diagnosis, severity, and treatment course.
• FDA label: Confirms the indication for which the drug is prescribed is an approved use.
• Humana's formulary exception criteria: Download the current criteria from Humana's website or request them. Exception criteria typically include documented formulary-alternative failure, contraindication, or clinical inappropriateness.

## Criteria-Mapping Structure

List each formulary exception criterion from Humana's policy in the left column. In the right column, provide the specific evidence — chart note, prescription record, or prescriber statement — that satisfies each criterion. When this table demonstrates that every formulary alternative is either previously failed or clinically inappropriate, the exception request and the appeal both have a strong evidentiary basis.